3:45 PM - 4:15 PM | Featuring Karyn DiGiorgio, MSN, MS, RN, Chief Operating Officer, Quantum Leap Healthcare Collaborative; together with Laura J. van’t Veer, PhD, Leader, Breast Oncology Program, and Director, Applied Genomics, and Angela and Shu Kai Chan Endowed Chair in Cancer Research, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
A 501c(3) charitable organization, Quantum Leap Healthcare Collaborative was established in 2005 as a collaboration between medical researchers at University of California, San Francisco and Silicon Valley entrepreneurs. Their mission is to integrate high-impact research with clinical processes and systems technology, resulting in improved data management and information systems, greater access to clinical trial matching and sponsorship, and greater benefit to providers, patients and researchers. QLHC’s goal is to improve and save lives.
The founders of QLHC recognize that good ideas and research projects in a University setting were often “orphaned” at the end of a research project. These efforts were frequently left with no funds or organizational structure to adequately engage clinical providers and ultimately benefit patient care. In addition, the intellectual property often created as part of these research endeavors remain untapped and undeveloped.
QLHC supports the development and implementation of innovative ways to deliver better, less costly healthcare. They are committed to establishing unique collaborations across the medical, technology and bioscience industries: all necessary components to accelerate healthcare research into the marketplace. Their efforts focus on quality-of-care and quality-of-life issues, and to create initiatives that foster excellent clinical practices using quality improvement disciplines with a strong patient-centric focus.
Photo feature: Karyn DiGiorgio, MSN, MS, RN and Laura J. Van’t Veer, PhD
